白血病抑制因子(LIF)卵白蛋白偶聯(lián)物
OVA Conjugated Leukemia Inhibitory Factor (LIF)
CDF; D-FACTOR; HILDA; MLPLI; Cholinergic Differentiation Factor; Differentiation-Stimulating Factor; Melanoma-Derived LPL Inhibitor; Emfilermin
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
Mass spectrometry
通過ISO 9001、ISO 13485質(zhì)量體系認證
化學式
用法
Reconstitute in PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當?shù)臈l件下存儲，損失率低于5%。
相關(guān)產(chǎn)品
| 編號 | 適用物種：Sus scrofa; Porcine (Pig，豬) | 應用(僅供研究使用，不用于臨床診斷！) |
| RPA085Po01 | 白血病抑制因子(LIF)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| CPA085Po21 | 白血病抑制因子(LIF)卵白蛋白偶聯(lián)物 | Immunogen; SDS-PAGE; WB. |
| PAA085Po01 | 白血病抑制因子(LIF)多克隆抗體 | WB; IHC; ICC; IP. |
| PAA085Po08 | 白血病抑制因子(LIF)多克隆抗體 | WB; IHC; ICC; IP. |
| MAA085Po21 | 白血病抑制因子(LIF)單克隆抗體 | WB; IHC; ICC; IP. |
| SEA085Po | 白血病抑制因子(LIF)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA085Po | 白血病抑制因子(LIF)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| British?Journal of Anaesthesia | Leukemia inhibitory factor (LIF) potentiates antinociception activity and inhibits tolerance induction of opioids[pubmed:28077540] |
| Biological Rhythm Research | A study of altered cytokine rhythms associated with successful implantation in cows[10.1080/09291016.2017.1361159] |
| Integrated analysis of cancer stem cells-associated lncRNA-miRNA-mRNA network for ovarian cancer via microarray and Gene Expression Omnibus database[] |